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Activated CD8+ T cells discriminate infected
and tumor cells from normal self by recognizing
MHC class I-bound peptides on the surface of
antigen-presenting cells. The mechanism by
which MHC class I molecules select optimal
peptides against a background of prevailing
suboptimal peptides and in a considerably
proteolytic ER environment remained unknown.
Here, we identify protein disulfide isomerase
(PDI), an enzyme critical to the formation of cor-
rect disulfidebonds in proteins, as a component
of the peptide-loading complex. We show that
PDI stabilizes a peptide-receptive site by regu-
lating the oxidation state of the disulfide bond
in the MHC peptide-binding groove, a function
that is essential for selecting optimal peptides.
Furthermore, we demonstrate that human cyto-
megalovirus US3 protein inhibits CD8+ T cell
recognition by mediating PDI degradation, ver-
ifying the functional relevance of PDI-catalyzed
peptide editing in controlling intracellular
pathogens. These results establish a link be-
tween thiol-based redox regulation and antigen
processing.
INTRODUCTION
MHC class I molecules capture peptides derived from
both self and foreign intracellular proteins in the endoplas-
mic reticulum (ER) and present them to the cell surface for
screening by CD8+ T cells (Pamer and Cresswell, 1998).
Peptides are generated primarily in the cytosol by protea-
somes and are translocated into the ER by transporters
associated with antigen processing (TAPs) for binding tonewly synthesized MHC class I heavy chain (HC)/b2-
microglobulin (b2m) heterodimers (Momburg et al.,
1994b; Rock et al., 1994). TAPs exhibit relatively broad
substrate specificity, ‘‘preselecting’’ peptides with regard
to their lengths and sequences (Momburg and Hammerl-
ing, 1998). Because the peptide binding of individual class
I molecules is selectively controlled by allele-specific
peptide-binding motifs (Rammensee et al., 1993), most
TAP-translocated peptides are suboptimal for binding
MHC class I molecules. Quantitative estimations predict
that of the peptides translocated into the ER, only
0.001% are optimal peptides with correct binding motifs
(Lehner, 2003; Montoya and Del Val, 1999; Princiotta
et al., 2003). Furthermore, TAP-translocated peptides sur-
vive a peptidase-containing ER environment in which free
peptides have a short half-life (Heemels and Ploegh, 1994;
Roelse et al., 1994). These situations might reflect the
existence of specialized mechanisms for protecting
peptides from degradation and transferring peptides to
MHC class I molecules. Chaperones may bind some pep-
tides and thereby protect them against degradation
(Momburg et al., 1994a; Reits et al., 2003). The direct in-
volvement of these chaperones in optimal peptide load-
ing, however, has not yet been established.
As some viruses can replicate and release viral progeny
within 4 hr (Grubman and Baxt, 2004), cytotoxic T lympho-
cytes (CTLs) have a limited time interval in which theymust
recognize a cell as infected and control the further spread
of infection. Moreover, viruses have evolved multiple
strategies to interfere with the MHC class I antigen pre-
sentation pathway and prevent CTL recognition (Lehner,
2003). Particularly at early times after infection, antigenic
peptides might be present at very low frequency. Under
these constraints, speed and efficiency in selection of op-
timal antigenic peptides may play a critical role in promot-
ing recognition of the infected cell.
These reasons support the existence of a mechanism
whereby MHC class I molecules select peptides against
a background of prevailing suboptimal peptides andCell 127, 369–382, October 20, 2006 ª2006 Elsevier Inc. 369
considerable proteolytic activity in the ER. Current evi-
dence suggests that MHC class I molecules first bind pep-
tides indiscriminately to acquire initial cargo that is subse-
quently edited (Lewis and Elliott, 1998; Sijts and Pamer,
1997). Peptide editing presumably occurs through a pep-
tide-exchange mechanism. In support of the peptide-
exchange mechanism, MHC class I molecules retained
in the ER are capable of binding peptides up to 3 hr after
their biosynthesis (Sijts and Pamer, 1997). Furthermore,
the T134K A2mutant, which otherwise exits the ER rapidly
with binding of suboptimal peptides, efficiently binds opti-
mal peptides when it is retained in the ER of brefeldin
A-treated cells (Lewis and Elliott, 1998). The process of
peptide exchange may be facilitated by the cofactors
present in the ER in a manner analogous to the activity
of HLA-DM onMHC class II molecules in endosomal com-
partments (Kropshofer et al., 1996; Weber et al., 1996).
Recent work proposes that the multimolecular peptide-
loading complex, which consists of MHC class I, b2m,
TAP, calreticulin, ERp57, and tapasin (Elliott and Williams,
2005), controls peptide editing. This process favors the
most stable MHC class I-peptide complexes and thus in-
creases the chance of their recognition by T cells. Despite
the potential importance of peptide editing in regulating
the specificity of immunity and tolerance, little is known
about how the MHC class I peptide repertoire is edited.
Here we demonstrate that protein disulfide isomerase
(PDI), as a component of the antigen-processing machin-
ery, plays a critical role in stabilizing a peptide-receptive
site by regulating the oxidation of the a2 disulfide bond
in the MHC class I peptide-binding groove and that this
function is required for selecting optimal peptides. Our
findings also suggest that PDI serves as a peptide chaper-
one that enhances the speed and efficiency of optimal
peptide loading.We further demonstrate that human cyto-
megalovirus (HCMV) targets PDI for immune evasion,
verifying a critical function of PDI for epitope selection
with relevance to viral infections. Collectively, our studies
present a paradigm for how the editing of the MHC class I
peptide repertoire operates at the molecular level.
RESULTS
Identification of PDI as a Component
of the Peptide-Loading Complex
To identify a component of the peptide-loading complex
that could provide insight into the precise molecular
mechanism underlying optimal peptide loading, we puri-
fied TAP complexes from digitonin lysates of HeLa cells.
Both silver staining and subsequent analysis by tandem
mass spectrometry (MS/MS) revealed that several pro-
teins, including calreticulin, tapasin, MHC class I heavy
chain, b2m, and Ig g H chain, specifically associated
with TAP (Figure 1A). By MS/MS analysis of the 58 kDa
protein band, we found that this band was a mixture of
ERp57 and PDI. Given the association of PDI with TAP,
we suspected that PDI, whose functions include disul-
fide-bond oxidation, reduction, and isomerization (Noiva,370 Cell 127, 369–382, October 20, 2006 ª2006 Elsevier Inc.1999), might be a component of the peptide-loading com-
plex. We confirmed the identity of the TAP-associated
components by reprecipitating anti-TAP1 immunoprecip-
itates from digitonin lysates of radiolabeled HeLa cells
with the indicated antibodies (Figure 1B). TAP1, TAP2, ta-
pasin, class I heavy chain, calreticulin, ERp57, and PDI,
but not calnexin, were positively identified by reprecipita-
tion (Figure 1B).
To determine whether identification of PDI as part of the
peptide-loading complex was cell-type specific or due to
contamination during the isolation of TAP-associated
complexes, we used human lymphoid T1 and monocytic
U937 cells to repeat the experiments and included
ERp72, a member of the PDI family, and BiP, an ER chap-
erone, as controls. Reprecipitation of the TAP1 immuno-
precipitates with the indicated antibodies revealed that,
in both cell lines, the TAP immunoprecipitates contained
TAP1, ERp57, PDI, tapasin, and class I heavy chain but
did not contain ERp72 or BiP (see Figure S1B in the Sup-
plemental Data available with this article online). Also, in
the TAP immunoprecipitates from HeLa cells, ERp72
and BiP were not detected, despite their abundance in
the ER (Figure S1A). These results demonstrate that PDI
is a bona fide component of the peptide-loading complex
irrespective of cell type.
Specificity of PDI Activity in MHC Class I
Antigen Presentation
To investigate the function of PDI in MHC class I assem-
bly, we used RNA interference for knockdown of endoge-
nous PDI. Because prolonged expression (>3 weeks) of
PDI small interfering RNA (siRNA) resulted in cell death,
we were unable to establish stable siRNA transfectants.
To overcome this limitation, we cotransfected HeLa cells
with siRNA and a plasmid conferring puromycin resis-
tance. After 72 hr of puromycin enrichment, the transfec-
tants were used for experiments. As detected with the
conformation-specific mAb W6/32, surface expression
of fully folded class I molecules was reduced by 30 to
40%, whereas the surface level of unfolded free class I
heavy chains as quantitated by mAb HC10 staining was
increased by 20% to 30% in PDI knockdown cells com-
pared to cells expressing endogenous PDI (Figure 2A, first
panel). Since the mAb HC10 recognizes free class I heavy
chains and unfolded free class I heavy chains are retained
in the ER (Antoniou et al., 2002), free class I heavy chains
at the cell surface probably represent a population loaded
with low-affinity peptides that might dissociate during the
course of the assay. Unpredictably, depletion of PDI did
not affect the surface expression of several disulfide-
bonded glycoproteins (CD47, CD58, CD71, CD95, CD59,
and CD49f; Figure 2A), suggesting that in protein oxidative
folding, although PDI is known as a ubiquitous catalyst, it
is not essential for thematuration of these glycoproteins in
these cells. Alternatively, this result might indicate that the
oxidation of MHC class I molecules is more sensitive to
PDI levels than the oxidation of other PDI substrates is.
Furthermore, we did not observe increased expression
Figure 1. Identification of TAP-Associated Proteins
(A) Identification of TAP-associated proteins by MS/MS analysis. HeLa cells were lysed in 1% digitonin with 10 mM N-ethylmaleimide (NEM) and
immunoprecipitated with TAP1 antiserum. Proteins were resolved by SDS-PAGE, visualized by silver staining, and identified as indicated.
(B) Association of PDIwith components of the peptide-loading complex. HeLa cells were radiolabeled for 2 hr, lysed in 1%digitonin with NEM (10mM),
and immunoprecipitated with TAP1 antiserum. Associated proteins were stripped in 1% SDS and reprecipitated with the indicated antibodies.of other oxidoreductases of the PDI superfamily, such as
ERp57 and ERp72 (Figure 2B), which would indicate
a compensatory response. PDI depletion did not affect
expression of TAP1 and tapasin (Figure 2B) or the associ-
ation among class I heavy chains, TAP, and tapasin, as
shown by immunoprecipitation and reblotting experi-
ments, which revealed normal levels of the class I heavy
chains/TAP and the class I heavy chains/tapasin com-
plexes in PDI-depleted cells (Figures 2C and 2D, respec-
tively). To ascertain the functional relevance of PDI, we in-
fected MZ1851 RC cells with a vaccinia virus recombinant
expressing cytomegalovirus (CMV) pp65 and analyzed
the susceptibility of these cells to lysis by HLA-A2.1-re-
stricted, CMV pp65-specific cytotoxic T cells. PDI deple-
tion inhibited CTL activity (Figure 2E), indicating that PDI
plays a physiological role in MHC class I function.
Distinct PDI Domains Control the Maturation and
Optimal Peptide Loading of MHC Class I Molecules
PDI consists of four distinct domains arranged in the order
a-b-b0-a0 with a C-terminal acidic extension that contains
the KDEL ER retention sequence. The a and a0 domains
contain thiol oxidoreductase active sites (CXXC) sepa-
rated by two noncatalytic domains, b and b0 (Edman
et al., 1985). The b0 domain provides the principal site
for binding small (10 to 15 residues) peptides (Klappa
et al., 1998). Mutations within this site greatly reduce thebinding affinity for small peptide substrates, with the
I272A and F258W mutations having the greatest effect
(Pirneskoski et al., 2004). ERp57 does not possess the
general peptide-binding site that is found in PDI, suggest-
ing that PDI and ERp57 are dedicated to distinct functions,
either oxidation or reduction and isomerization. To identify
the discrete role of each domain in MHC class I assembly,
we constructed several PDI proteins with deletion or point
mutations (Figure 3A). By engineering PDI siRNA oligo-
mers corresponding to the a0 domain, we analyzed the ex-
clusive effect of each mutated protein on class I assembly
in a background depleted of endogenous PDI. HeLa cells
expressing each mutant were pulse chased, and the
lysates were analyzed by an assay that correlates thermo-
stability with the affinity of class I peptide cargo (Williams
et al., 2002). In PDI-depleted cells, MHC class I molecules
exhibited slow maturation and poor thermostability when
compared to cells in constitutive PDI expression (Fig-
ure 3B, compare lanes 7–12 and 1–6). In cells with con-
stitutive PDI expression, 95.6% of labeled MHC class I
molecules had matured to endoglycosidase H (endo H)-
resistant forms 30 min after synthesis, whereas in PDI-
depleted cells, only 39.7% of MHC class I molecules
were endo H resistant during the same period (Figure 3B,
fourth panel, lanes 2 and 8). In cells depleted of PDI by
siRNA, MHC class I molecules were less thermostable
than cells in constitutive PDI expression, and, in particular,Cell 127, 369–382, October 20, 2006 ª2006 Elsevier Inc. 371
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almost no MHC class I complexes could be recovered at
50C (Figure 3B, lanes 11 and 12). Interestingly, in endog-
enous PDI-depleted cells, expression of PDI-abb0, but not
PDI-ab, restored the maturation rate and thermostability
of class I molecules to an extent comparable to the consti-
tutive condition (Figure 3B, lanes 13–18 and 19–24), es-
tablishing the importance of the b0 domain in regulating
optimal peptide loading and normal maturation of MHC
class I molecules. Expression of PDI-F258W/I272A, which
serves as a dominant-negative mutant regarding peptide
binding, resulted in MHC class I molecules acquiring
endo H resistance and thermostability similar to that of
cells expressing PDI-ab/siRNA or siRNA alone
(Figure 3C, lanes 13–18). These results confirm that the
peptide-binding property of the b0 domain is indeed criti-
cal not only for optimal peptide loading but also for normal
maturation of class I molecules. The PDI-C36,39S point
mutation, in which the catalytic site of the a domain is de-
stroyed, also failed to restore thermostability (Figure 3C,
lanes 7–12). MHC class I molecules in these transfected
cells were rapidly transported out of the ER, as evidenced
by endo H resistance. Poor thermostability and faster
transport kinetics of MHC class I molecules with the
PDI-C36,39S point mutation reflect suboptimal peptide
loading and escape from ER quality control. From these
experiments, we have established that both the catalytic
function of the a domain and the peptide-chaperoning
function of the b0 domain of PDI are essential for optimal
peptide loading.
Peptide Editing and Thiol-Based Redox Regulation
Are Linked
Identification of PDI within the peptide-loading complex
suggests that it might regulate the redox state of MHC
class I molecules, leading to optimal peptide loading.
We examined whether PDI catalyzes intrachain disulfide
linkage in class I heavy chains. MHC class I molecules
contain two disulfide bonds, one in the a2 domain and
the other in the a3 domain, which influence the association
of free heavy chain with b2m (Bjorkman et al., 1987; Smith
et al., 1995; Tector et al., 1997). In agreement with a previ-
ous study (Warburton et al., 1994), A2.1-C101S, a cyste-
ine-to-serine substitution mutation at position 101 of the
A2.1molecule, failed to form a disulfide bond, as indicated
by the reduced form in the nonreducing condition (Fig-
ure 4A, lane 9). In cells that express endogenous PDI or
PDI-abb0, A2.1 molecules became oxidized, indicative ofintradisulfide bond formation (Figure 4A, lanes 8 and 11).
In contrast, PDI depletion by siRNA or expression of
PDI-C36,39S in cells depleted of endogenous PDI re-
sulted in partial reduction of A2.1 molecules (Figure 4A,
lanes 10 and 14, respectively). A2.1 molecules were re-
duced in the presence of PDI-ab or PDI-F258W/I272Amu-
tants in which the catalytic site of the a domain remains
intact (Figure 4A, lanes 12 and 13), demonstrating that
not only the oxidoreductase activity of the a domain but
also the peptide-binding property of the b0 domain influ-
ences the redox state of class I molecules. If the binding
of peptides to PDI were vital for PDI-mediated oxidation
of class I molecules, depletion of the ER peptide pool
should lead to results similar to those observed in cells ex-
pressing themutant proteins but lacking the peptide-bind-
ing site, such as PDI-ab or PDI-F258W/I272A. To test this
assumption, we blocked the peptide supply into the ER lu-
men by using the ICP47 or US6 proteins, viral TAP inhibi-
tors (Ahn et al., 1997; Hill et al., 1995). As expected, in the
HeLa cells stably expressing US6 or ICP47, the surface
expression of MHC class I molecules was downregulated
(Figure 4B, left panel). In the same cells, the reduced form
of class I heavy chains was increased (Figure 4B, right
panel, lanes 7 and 8), indicating that availability of pep-
tides is a crucial factor for determining the redox state of
MHC class I molecules.
Next we tested whether, in addition to peptide availabil-
ity, the nature of peptides influences the redox state of
class I molecules. Initially we examined whether PDI pref-
erentially binds high-affinity peptide ligands for MHC class
I molecules. Photocrosslinking analysis revealed that both
ILMEKIHKV and IDMEKIHK peptides (high- and low-affin-
ity peptides for A2.1, respectively) (Rammensee et al.,
1999) can bind TAP, PDI, and PDI-abb0, but not PDI-ab
(Figure S2). This result suggests that the b0 domain of
PDI binds, although the crosslinking assay is limited in
quantitative measurement of affinity differences, a broad
spectrum of peptides, not necessarily antigenic ones.
Upon exogenous supply of high-affinity peptides, A2.1
molecules became oxidized (Figure 4C, left panel, lane
5). In contrast, in the presence of low-affinity peptides,
A2.1 showed predominantly the reduced form (Figure 4C,
left panel, lane 6), similar to the redox state of A2.1 mole-
cules in the peptide-depleted condition by ICP47 or US6
(Figure 4B). To confirm the results obtained with synthetic
exogenous peptides, we performed a similar analysis
by using the minigene expression system. MinigenesFigure 2. Specificity of PDI in MHC Class I Antigen Presentation
(A) Effect of PDI on the surface expression of class I molecules. Top panels: HeLa cells expressing PDI siRNA (+siRNA) or mock (siRNA) were as-
sayed for surface levels of MHC class I molecules and disulfide-bonded glycoproteins.siRNA, thin line; +siRNA, thick line; control antibody staining,
dotted line. Bottom panel: The mean fluorescence intensity (MFI) value obtained in PDI siRNA-expressing HeLa cells was set as 1, and the difference
in MFI induced by siRNA expression was plotted.
(B) Effect of PDI on the steady-state level of components of the peptide-loading complex. Extracts from HeLa cells were analyzed by immunoblotting
with the specified antibodies.
(C and D) PDI does not affect the association between class I molecules and TAP or tapasin. HeLa cells were lysed in 1% digitonin with a cocktail of
protease inhibitors. Postnuclear lysates were immunoprecipitated (I.P) with class I-specific K455 antibody and immunoblotted (I.B) with anti-TAP (C)
or anti-tapasin antibody (D).
(E) PDI knockdown inhibits CTL activity. Error bars represent standard deviations from triplicate wells.Cell 127, 369–382, October 20, 2006 ª2006 Elsevier Inc. 373
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encoding either MIINFEKL or MIPAQFYIL (low- and high-
affinity peptides for A2.1, respectively) were overex-
pressed under a CMV promoter in A2.1-HeLa cells. A2.1
molecules became oxidized with high-affinity peptides
(Figure 4C, right panel, lane 5), whereas A2.1 showed pre-
dominantly the reduced form with low-affinity peptides
(Figure 4C, right panel, lane 6), essentially the same redox
state of A2.1 molecules as observed with exogenous pep-
tides. These results indicate that the nature of peptides
also influences the redox state of class I molecules.
Synergistic Action of the a2 Disulfide Bond
and Peptide Binding Drives Selection
of Optimal Peptides
We investigated separately the redox state of the pool of
MHC class I molecules that did or did not associate with
the peptide-loading complex. We transfected ICP47-
expressing HeLa cells with either mock or PDI siRNA (Fig-
ure 5A). After metabolic labeling of cells for 1 hr, we used
anti-TAP1 antibody to immunoprecipitate the peptide-
loading complex from digitonin lysates containing equal
numbers of cells. After twomore rounds of immunoprecip-
itation with anti-TAP1 and anti-b2m antibodies, the resid-
ual TAP-associated proteins and MHC class I-b2m heter-
odimers were completely removed from the supernatant
(Figure 5B, first panel). Regardless of the availability of
peptides, about 10% to 15% of the total pool of cellular
PDI was associated with the peptide-loading complex
(Figure 5B, second panel, P1 and P3). In the steady state,
over 90% of the total pool of cellular MHC class I mole-
cules were associated with the peptide-loading complex
(Figure 5B, third panel, compare P1 and S1), and this
pool was fully oxidized in mock-transfected cells (Fig-
ure 5B, fourth panel, P1). The amount of class I molecules
that associated with the peptide-loading complex in either
PDI- or peptide-depleted cells was only 40% to 60% of
the total pool of class I molecules (Figure 5B, third panel,
P2 and P3). Most surprisingly, the class I molecules within
the peptide-loading complex were partially reduced (Fig-
ure 5B, fourth panel, P2 and P3), suggesting that, in the
peptide-loading complex, class Imolecules are in dynamic
equilibrium between an oxidized and reduced state, with
equilibrium predominantly shifted to oxidation at the
steady state. In cells that were depleted of both peptides
and PDI, only trace amounts of class I molecules were as-
sociated with the peptide-loading complex (Figure 5B,
third panel, P4), and this population represented predom-
inantly the reduced form (Figure 5B, fourth panel, P4). Thepool of class I molecules outside the peptide-loading
complex showed exclusively the reduced form (Figure 5B,
fourth panel, S1, S2, S3, and S4). The reduced disulfide
bond within the peptide-loading complex seems very
likely to be the one in the a2 domain (Figure 5E). The disul-
fide bond in the Ig-like a3 domain forms early after biosyn-
thesis (Tector et al., 1997) and, once formed, is unlikely to
be involved in further reduction because it is buried in the
hydrophobic core of the Ig-like a3 domain (Dick, 2004).
We hypothesized that if PDI participates in a2 disulfide
oxidation and reduction, PDI-class I heavy-chain disulfide
intermediates might exist. We dissolved the TAP precipi-
tates in nonreducing buffer containing 1% SDS and 10
mM N-ethylmaleimide (NEM), reprecipitated the diluted
sample with K455 antibody (which recognizes class I
heavy chain and b2m in both assembled and nonas-
sembled forms), and resolved the elutedmaterial in nonre-
ducing conditions. In mock-transfected conditions (P1),
we detected, within the peptide-loading complex, faint
but reproducible PDI-class I intermediates with an appar-
ent molecular weight of 105 kDa (Figure 5C, lane 3). We
used as many as 53 108 cells to detect this intermediate,
anticipating that it would be extremely short lived. To con-
firm the identity of the intermediates, aliquots of the K455
reprecipitates were dissolved in 1% SDS, immunoprecip-
itated again with either K455 or anti-PDI antibody, and an-
alyzedbySDS-PAGE in reducing conditions. Indeed, class
I heavy chains and PDI were positively identified (Fig-
ure 5C, lanes 1 and 2). In peptide-depleted cells, the
amount of PDI-class I heavy-chain intermediates inside
the peptide-loading complex (P3) was significantly in-
creased compared to the amount in mock-transfected
cells (Figure 5C, compare lanes 9 and 3). The pool of free
class I heavy chains outside the peptide-loading complex
(S1 and S3) was also disulfide linked to PDI (Figure 5C,
lanes 6 and 12) and was subsequently subjected to pro-
teasome-mediated degradation (Figure 5D, upper panel,
compare lanes 2 and 6). HCMV US11 was used as a posi-
tive control for proteasome-mediated degradation of class
Imolecules (Wiertz et al., 1996). In contrast, the class I pool
within the peptide-loading complex (P) was stable under
the same conditions (Figure 5D, lower panel, lanes 1–4).
Thus, the PDI-class I heavy-chain conjugates outside the
peptide-loading complex most likely represent the pool
released from the peptide-loading complex rather than
early folding intermediates during biosynthesis. These re-
sults argue strongly that, although PDI functions primarily
as an oxidase, PDI can also reduce the a2 disulfide bondFigure 3. Distinct PDI Domains Control the Maturation and Optimal Peptide Loading of MHC Class I Molecules
(A) Schematic representation of deletion or point mutants of PDI.
(B) Distinct role of each domain in thematuration and peptide loading of class I molecules. HeLa cells expressing PDI siRNAwere transfected with the
indicated deletion mutants; pulse labeled for 5 min; and chased for 0, 5, 15, or 30 min. After lysis in 1% NP-40, equal aliquots of the lysates were
incubated at 4C, 37C, and 50C for 1 hr and then immunoprecipitated with the mAb W6/32. The W6/32 precipitates were digested with endo H
and analyzed by SDS-PAGE. For estimating thermostability, the percentage of class I molecules that survived heating to 50C was plotted in relation
to the value at 4Cat the 30min time point. The ER exit rate was estimated by calculating the ratio of [r] band to the total protein ([r] + [s]) at 4C for each
time point. HLAr, endo H resistant; HLAs, endo H sensitive.
(C) Analysis similar to that in (B), except that each point mutant was cotransfected with siRNA.Cell 127, 369–382, October 20, 2006 ª2006 Elsevier Inc. 375
Figure 4. Link between Loading of Optimal Peptides and Thiol-Based Redox Regulation
(A) The catalytic and peptide-binding residues of PDI are critical for regulating the redox state of class I molecules. HeLa cells expressing the indicated
combination of constructs were radiolabeled for 10 min. Postnuclear supernatants of 1% NP-40/10 mM NEM lysates were immunoprecipitated with
the A2.1-specific BB7.2 antibody, and proteins were separated by SDS-PAGE under reducing and nonreducing conditions.
(B) Peptide starvation increases the level of the reduced class I molecules. The assay was performed as described in (A), but using HeLa cells stably
expressing US6 or ICP47.
(C) The nature of peptides influences the redox state of class I molecules. A2.1-expressing HeLa cells were either incubated with exogenous peptides
(10 mM) for 48 hr (left panel) or transfected with minigenes encoding either a high-affinity or low-affinity peptide ligand for A2.1 (right panel). The assay
was performed as described in (A).376 Cell 127, 369–382, October 20, 2006 ª2006 Elsevier Inc.
at a rate determined by the availability and nature of
peptides.
To further identify the PDI-binding cysteine residue, we
constructed a series of A2.1 cysteine mutations and found
that they failed to integrate into the peptide-loading com-
plex. In addition, detecting the A2.1 cysteine mutant-PDI
conjugates was difficult because they were unstable
(B.P. and K.A., unpublished data). We circumvented this
problem by overexpressing A2.1 cysteine mutants and
myc-tagged PDI simultaneously in HeLa cells and pulsing
the cells for only 5 min. We found that cysteine-to-serine
mutations in the a2 region (A2.1-C101S and A2.1-
C164S), but not the cysteine-to-serine mutation in the a3
region (A2.1-C203S), disrupted the A2.1-PDI conjugate
(Figure 5E), indicating that the PDI-binding cysteine is
the one in the a2 domain. Together, these results strongly
suggest that PDI directly catalyzes the making and break-
ing of a2 disulfide bonds.
Viral Targeting of PDI-Catalyzed Editing
of the Peptide Repertoire for Immune Evasion
Wehave shown that the human cytomegalovirus US3 pro-
tein interferes with the editing of the peptide repertoire of
certain class I alleles and that anti-US3 immunoprecipi-
tates obtained from digitonin lysates contain an unknown
protein of about 60 kDa, the size of PDI (Park et al., 2004).
To explore the possibility that PDI might be an ultimate
cellular target for the action of US3, we examined whether
US3 and PDI colocalize in the ER. In HeLa cells transiently
expressing US3, the staining patterns of both US3 andPDI
were analyzed by immunofluorescence staining. Surpris-
ingly, we observed that the staining intensity of PDI was
markedly diminished in the cells expressing US3 (Fig-
ure 6A), suggesting that US3 might cause PDI degrada-
tion. We therefore quantitated PDI in US3-expressing
HeLa (HeLa-US3) cells by immunoblotting cell lysates
with anti-PDI antibody, which recognizes either the C ter-
minus (residues 499–509) or the b domain (residues 211–
370) of PDI. PDI was almost completely absent from the
HeLa-US3 cells (Figure 6B, first and second panel). This
reduced level of PDI was not due to the masking of anti-
genic epitopes, as immunoblot analysis of the cell lysates
of myc-tagged PDI transfectants with anti-myc antibody
(Figure S3) revealed essentially the same result. We hy-
pothesized that US3must associate with PDI so as to trig-
ger degradation. We examined the physical association of
US3 and PDI in digitonin lysates of HeLa-US3 cells in the
presence of MG-132. In anti-US3 coimmunoprecipitates,
tapasin, class I heavy-chain molecules, and PDI were
identified, indicated by reprecipitation with antibodies
specific to each protein (Figure 6C). Thus, US3 associates
with PDI, although a possible requirement for other pro-
teins in the complex was not excluded. Most importantly,
expression of US3 resulted in an increase in the steady-
state level of the reduced form of A2.1 molecules in a
dose-dependentmanner (Figure 6D, lanes 8 and 9), similar
to the redox state of A2.1 molecules in the cells depleted
of PDI by siRNA (Figure 4A). These results demonstratethat the HCMV US3 protein exploits PDI degradation for
CD8+ T cell evasion, reflecting the functional relevance
of PDI-mediated peptide editing against viral infections.
DISCUSSION
Our findings reveal a mechanism by which thiol-based re-
dox reactions regulate the editing of the MHC class I pep-
tide repertoire. The steady-state level of the reduced class
I form was dependent on both the abundance and nature
of peptides in the ER. Lack of peptides, or a supply of low-
affinity peptides, led to an increase in the reduced class I
form (Figure 4). Suboptimal peptides with a faster off rate
might render the a2 disulfide bond more vulnerable to PDI
reductase activity, whereas a high-affinity peptide, which
will firmly fit into the MHC peptide-binding groove and
have a longer off rate, makes the bond less susceptible
to reduction. This idea is further strengthened by the
three-dimensional structures of MHC class I molecules,
which predict the burial of the a2 disulfide bond in the
presence of peptides (Bjorkman et al., 1987). Our data in-
dicate that, in the peptide-loading complex, most of the
class I molecules are oxidized but the reduced form exists
(Figures 5B–5D), suggesting equilibrium of a rapid thiol di-
sulfide exchange between PDI and a2 disulfide, with oxi-
dation of a2 disulfide heavily favored in the steady state.
Taking into account this notion and the result that oxida-
tion of the a2 disulfide bond is required for optimal peptide
loading, we propose that the primary function of PDI in
peptide loading is to keep the a2 disulfide bond oxidized.
Based on the observation that mutagenesis of the N-
terminal cysteines of tapasin disrupts formation of the
ERp57-tapasin bond and renders class I molecules par-
tially reduced, it has been proposed that the ERp57-tapa-
sin conjugate is involved in the isomerization of the class I
a2 disulfide bond and thus facilitates peptide loading (Dick
et al., 2002). Arguing against the direct involvement of the
ERp57-tapasin conjugate in isomerization of the class I a2
disulfide bond, analysis of ERp57-deficient mice shows
that ERp57 does not influence the redox state of class I
molecules but is an essential structural component for
stable assembly of the peptide-loading complex (Garbi
et al., 2006). Depletion of ERp57 by siRNA also does not
affect the redox state of class I molecules and peptide
loading (Zhang et al., 2006). Moreover, neither ERp57-
class I nor tapasin-class I conjugates, the expected disul-
fide intermediates if class I heavy chains are reoxidized by
ERp57 or tapasin, have been identified. Considering the
critical nature of the N-terminal region of tapasin for stabi-
lizing the peptide-receptive class I structure (Bangia et al.,
1999), the increase of the reduced class I form with the
tapasin mutant likely represents the secondary effect
of peptide loading into a loosely folded class I binding
groove, which mimics suboptimal peptide binding.
Our work also suggests that PDI is a chaperone for
antigenic peptides. Expression of PDI-F258W/I272A, a
dominant-negative point mutant regarding peptide bind-
ing, results in partial reduction of MHC class I moleculesCell 127, 369–382, October 20, 2006 ª2006 Elsevier Inc. 377
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(Figure 4A) and severely impairs optimal peptide loading
(Figure3C).Althoughwedonot knowwhether the impaired
peptide loading mediated by the PDI-F258W/I272A mu-
tant resulted from the loss of peptide-carrier function or
from a side effect that caused loss of catalytic function,
this result implicates that the peptide-chaperoning prop-
erty of the b0 domain might be critical for optimal peptide
loading. Of note, in this condition, the MHC class I mole-
cules are not empty but are still loaded with suboptimal
peptides, suggesting a role for PDI in facilitating the speed
and efficiency of optimal peptide selection. This result rec-
onciles a seemingly contradictory observation byLammert
et al. (1997) in which b-estradiol inhibits peptide binding to
PDI but not binding toMHCclass Imolecules, observed by
chemical crosslinking. In the presence of b-estradiol, the
peptides crosslinked to MHC class I molecules could be
low-affinity peptides. Indeed,we found that, in b-estradiol-
treated cells, MHC class I molecules were less thermosta-
ble than those in mock-treated cells (Figure S4). Consis-
tent with the proposed role for PDI as a peptide carrier,
the b0 domain of PDI, including the hydrophobic binding
pocket, recognizes small peptides of 10 to 15 amino acids
(Pirneskoski et al., 2004), andPDI is the dominant acceptor
for TAP-translocated peptides (Lammert et al., 1997; Spee
and Neefjes, 1997). As a peptide chaperone, PDI might
facilitate optimal peptide loading either by protecting free
peptides from the ER proteases or by delivering peptides
into the class I molecules, or optimal loading might involve
bothmechanisms. Free peptides have a very short half-life
in vivo and are most likely protected from degradation by
their association with chaperones (Reits et al., 2003).
With the selective pressure of the host immune re-
sponse, viruses have evolved several strategies to inter-
fere with the antigen presentation pathway (Lilley and
Ploegh, 2005). Our previous study showed that the
HCMV US3 protein targets the peptide-loading complex
and specifically interferes with peptide editing of MHC
class I molecules (Park et al., 2004). Interestingly, this
study showed that the inhibitory effect of US3 on peptide
editing is more profound for tapasin-dependent class Ialleles. Since PDI, ERp57, and tapasin are components
of the peptide-loading complex and contain free cysteine
residues, the possibility exists that PDI controls the redox
network of tapasin involving ERp57. Assuming that PDI is
indeed an upstream regulator of the tapasin redox net-
work, and given that US3 triggers the degradation of PDI
(Figure 6), the inhibition of editing of the MHC class I pep-
tide repertoire observed in the presence of US3 might
occur, in fact, via US3-mediated degradation of PDI. Our
finding that the HCMVUS3 protein targets PDI for immune
evasion, regardless of the mechanism, underlines the
critical role of PDI-mediated editing of the class I peptide
repertoire in normal immune function.
In summary, we propose that editing of the MHC class I
peptide repertoire involves two linked equilibriums: a rapid
thiol disulfide exchange between PDI and the MHC class I
a2 disulfide, and competition between peptides of various
affinities for MHC class I binding (Figure 7). After oxidation
of the a2 disulfide bond of MHC class I molecules in the
peptide-loading complex, PDI transfers a peptide to the
class I peptide-binding groove. Then, peptides compete
for MHC binding until the MHC-peptide interaction in-
duces a conformational change that is sufficient to trigger
the release of the MHC-peptide from the peptide-loading
complex, ultimately favoring the presentation of the most
stable MHC-peptide complexes. Reduced class I mole-
cules that fail to be rescued by reoxidation are prone to ir-
reversible dissociation from the peptide-loading complex
and proteolysis. Thus, the redox status of MHC class I
molecules might be a checkpoint for quality control of
MHC class I assembly. This regulated process would al-
low the host to induce rapid and sustained CTL responses
against invading pathogens and, at the same time, avoid
unwanted immune responses.
EXPERIMENTAL PROCEDURES
DNA Constructs
cDNAs encoding human PDI and PDI deletion mutants, kindly pro-
vided by Dr. Y. Nomura (Hokkaido University, Sapporo, Japan), wereFigure 5. PDI Directly Catalyzes Reduction and Oxidation of the a2 Disulfide Bond in the MHC Peptide-Binding Groove
(A) Schematic representation of the experimental protocol. Mock- or ICP47-expressing HeLa cells were transfected without (+PDI) or with (PDI) PDI
siRNA. 1% digitonin/10 mM NEM extracts of radiolabeled (60 min) cells were precipitated by TAP1 antiserum. The TAP immunoprecipitates were
designated as P1–P4, and the corresponding supernatants were designated as S1–S4.
(B) Effect of peptides and PDI on the redox state of class I molecules. 1% NP-40/1% SDS/10 mM NEM eluates from P1–P4 were reprecipitated with
the class I-specific K455 antibody. S1–S4 were directly immunoprecipitated with K445 and analyzed by reducing or nonreducing SDS-PAGE (third
and fourth panels). P1–P4 and S1–S4 were also analyzed for the levels of TAP (first panel) and PDI (second panel).
(C) Existence of the disulfide intermediate between PDI and class I molecules. 1% SDS/10 mMNEM eluates from P1 and P3 were reprecipitated with
K455 and analyzed by nonreducing SDS-PAGE (lanes 3 and 9). The identities of the protein bandswere confirmed by dissolving K455 reprecipitates in
1% SDS, reprecipitating with either K455 or PDI antisera, and analyzing proteins by reducing SDS-PAGE (lanes 1, 2, 7, and 8). This analysis was
repeated for S1 and S3. PDI-class I conjugates (black asterisk), PDI (black arrow), and class I molecules (white arrow) are indicated.
(D) Fate of PDI-conjugated class I molecules outside the peptide-loading complex. HeLa cells expressing the HCMV US11 glycoprotein were radio-
labeled for 10 min and chased for 1 hr with or without 50 mMMG-132. The TAP immunoprecipitates (P) and corresponding supernatants (S) were pre-
pared as described in (A). The supernatantswere directly used for immunoprecipitationwith K455 and analyzed by reducing SDS-PAGE (upper panel).
TheTAP immunoprecipitateswere stripped in 1%SDS, and theclass Imoleculeswere reprecipitatedwithK455prior to endoH treatment (lower panel).
(E) Identification of cysteine residues that bind PDI. MG-132-pretreated HeLa cells were cotransfected with PDI-myc and HLA-A2.1 or A2.1 cysteine
mutants. Transfected cells were radiolabeled, lysed in 1% digitonin with 10 mM NEM, and immunoprecipitated with mAb BB7.2. One percent SDS
eluates from the BB7.2 immunoprecipitates were reprecipitated with anti-myc or K455 antisera and analyzed by reducing or nonreducing SDS-
PAGE. PDI is marked with the white arrow.Cell 127, 369–382, October 20, 2006 ª2006 Elsevier Inc. 379
Figure 6. Virus Subversion of PDI for Immune Evasion
(A) Intracellular distribution of PDI in the presence of US3. HeLa cells were transfected with US3-GFP cDNA. Cells were stained with the anti-PDI
C-terminal antibody. Bound primary antibodies were labeled with Texas red-conjugated anti-mouse secondary antibodies.
(B) Reduced levels of PDI in cells expressing US3. Lysates from HeLa-US3 cells were immunoblotted for US3 and PDI with the indicated antibodies.
(C) Association of US3 with PDI. HeLa-US3 cells were radiolabeled, lysed in 1% digitonin/NEM (10 mM), and immunoprecipitated with the anti-US3
antibody. Associated proteins were stripped in 1% SDS and reprecipitated with indicated antibodies.
(D) US3 results in an increase in the level of the reduced class I molecules. HeLa cells (13 106 cells) were cotransfected with A2.1 (2 mg) and either 2 mg
(lane 8) or 4 mg (lane 9) of US3 cDNAs and radiolabeled for 10min. Cell extracts were immunoprecipitatedwith mAbBB7.2, and the redox state of A2.1
was analyzed by SDS-PAGE in reducing and nonreducing conditions.inserted into the mammalian expression vector pcDNA3.1 (Invitrogen,
San Diego, CA, USA). Isoleucine-to-alanine (I272A) and phenylalanine-
to-tryptophan (F258W) replacement mutations within the b0 domain of
PDI and the cysteine-to-serine (C36, 39S) mutation in the a domain of
PDI were made by site-directed mutagenesis with Pfu DNA Polymer-
ase (Stratagene, San Diego, CA, USA). The siRNA construct for human
PDI was generated by cloning the cDNA segment encoding residues
1243–1261 (GGACCATGAGAACATCGTC), corresponding to the
a0 domain of PDI, into the pSilencer2.1-U6 neo vector (Ambion, Austin,
TX, USA). This siRNA provides knockdown of only PDI that contains
the a0 domain.380 Cell 127, 369–382, October 20, 2006 ª2006 Elsevier Inc.Cell Lines and Antibodies
All constructs encoding deletion or point mutations were cotrans-
fected with PDI siRNA into HeLa cells. The cells were partially
selected by adding 1 mg/ml of puromycin to the growth medium
(Sigma-Aldrich, St. Louis) for 3 days prior to analysis. T1, U937, and
HLA-A2.1-expressing renal carcinoma MZ1851 RC cells were grown
in RPMI 1640 medium supplemented with 10% FBS. Most antibodies
used in this study have been described (Park et al., 2004; Wiertz et al.,
1996). The human tapasin (R.gp48N) and human calnexin antibodies
were kindly provided by Dr. P. Cresswell (Yale University, New Haven,
CT, USA). The mAb ERp57 and anti-b2m antibody BBM.1 were
Figure 7. Hypothetical Model for PDI-Mediated Editing of the MHC Class I Peptide Repertoire
In the peptide-loading complex, the a2 disulfide of the MHC class I molecule is in dynamic equilibrium between oxidized and reduced states, with
equilibrium predominantly shifted to oxidation at the steady state. Peptides of various affinities that are transferred by PDI compete to bind the ox-
idized class I molecule, a peptide-receptive form. OnlyMHC class I molecules with the a2 oxidized and that contain high-affinity peptides are selected
for ER exit. Reduced class I molecules are either rapidly rescued by reoxidation for peptide binding or subjected to irreversible loss via dissociation
from the peptide-loading complex and proteolysis.purchased from Santa Cruz Biotechnology (Santa Cruz, CA, USA). The
anti-PDI antibodies recognizing the C terminus or b domain were from
StressGen Biotechnologies (Victoria, BC, Canada) and BD Biosci-
ences (San Jose, CA, USA), and anti-ERp72 and anti-CD series anti-
bodies were from BD Biosciences.
Purification of TAP-Associated Proteins
HeLa cells were lysed in 1% digitonin with 10 mM NEM, and post-
nuclear lysates were immunoprecipitated with the anti-TAP1 antibody.
Proteins were separated by SDS-PAGE and visualized by silver
staining. Proteins in gel slices were digested with trypsin (Shevchenko
et al., 1996) and analyzed by MS/MS (Bahk et al., 2004) as described.
Proteins were identified by comparing experimental data to the
NCBInr database by using the MASCOT search program (Matrix
Science).
TAP Depletion Assays
HeLa cells expressing ICP47 or PDI siRNA were radiolabeled for 1 hr
and solubilized in 1% digitonin with 10 mM NEM and protease inhibi-
tors. Postnuclear lysates were immunoprecipitated with anti-TAP1 an-
tibodies, and the TAP immunoprecipitateswere designated as P (pellet
fraction). The pool of pure free heavy chains was obtained by further
preclearing of the resulting supernatants by immunoprecipitation
with the b2m-reactive BBM.1 antibody, which removed the class I-
b2m heterodimers, and was designated as S (supernatant fraction).
For analysis of the redox state of class I heavy chains in the TAP pre-
cipitates or supernatant fractions, TAP-associated proteins were
eluted by heating to 95C in 1% SDS, and the eluted proteins were
then diluted into 1% NP-40 in PBS and reprecipitated with K455.
The supernatant fractions were used directly for immunoprecipitation
with K455 and eluted by reducing or nonreducing buffer. For detecting
the PDI-class I heavy-chain intermediates and to confirm the identity of
the intermediates, labeled cells were lysed in 1% digitonin in the pres-
ence of 10 mM NEM, immunoprecipitated with K455, and analyzed by
nonreducing SDS-PAGE. Aliquots of the K455 immunoprecipitates
were eluted in 1% SDS, and the eluted proteins were diluted into 1%
NP-40 in PBS, reprecipitated again with K455 or PDI antibody, and
analyzed by reducing SDS-PAGE.Supplemental Data
Supplemental Data include Supplemental Experimental Procedures,
SupplementalReferences, and fourfiguresandcanbe foundwith thisar-
ticle online at http://www.cell.com/cgi/content/full/127/2/369/DC1/.
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